Trevena, Inc. (NASDAQ:TRVN – Get Free Report)’s share price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.01 and traded as high as $0.0111. Trevena shares last traded at $0.0111, with a volume of 654 shares.
Trevena Price Performance
The company has a market capitalization of $10,644.90, a price-to-earnings ratio of -0.00 and a beta of 0.18. The stock has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.01.
About Trevena
Trevena, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of biased ligand G protein-coupled receptor (GPCR) selective medicines. By leveraging its proprietary bias-ligand technology platform, Trevena aims to create therapies that preferentially activate beneficial signaling pathways while minimizing engagement of pathways linked to adverse effects. The company’s research efforts target areas of high unmet medical need, including pain management, cardiometabolic disorders and central nervous system conditions.
The company’s lead compound, oliceridine (also known by its brand name OLINVEO), is a G protein-biased μ-opioid receptor agonist designed for the treatment of moderate to severe acute pain in the hospital setting.
See Also
- Five stocks we like better than Trevena
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
